首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1540841

2024-2032 年神經退化性疾病治療市場報告（按適應症、藥物類型、給藥途徑、配銷通路和地區）

Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球神經退化性疾病治療市場規模達747億美元。

神經退化性疾病是指導致中樞神經系統（CNS）或周邊神經系統（PNS）神經元結構和功能進行性退化的一組腦部疾病。目前，有幾種藥物可以減輕身體或精神症狀並改善患者的生活品質。此外，研究人員正致力於開發分子診斷技術，特別是生物標記和成像光譜學，以在早期階段檢測和診斷神經退化性疾病並防止其進展。

由於過量飲酒而導致的腫瘤和中風盛行率不斷上升，加上老年人口不斷增加，這是增加神經退化性疾病風險的主要因素之一。這進一步增加了對分子診斷技術的需求，以早期診斷神經退化性疾病，包括阿茲海默症、帕金森氏症、亨丁頓舞蹈症和肌萎縮性側索硬化症。除此之外，研究人員正在將神經病理學方法與分子生物學技術結合，以有效地了解這些疾病的分類。他們也正在開發針對不同類型神經退化性疾病的微創（MI）篩檢測試。此外，許多國家的管理機構以及非政府組織 (NGO) 正在支持各種健康教育活動，以提高人們對神經退化性疾病風險因素的認知。其他因素，例如由於基礎設施改善和可支配收入增加而增加使用醫療保健設施的機會，預計將在未來幾年推動市場的成長。

本報告回答的關鍵問題：

迄今為止，全球神經退化性疾病治療市場表現如何，未來幾年將如何表現？
COVID-19 對全球神經退化性疾病治療市場有何影響？
主要區域市場有哪些？
根據指示，市場的細分是什麼？
根據藥物類型分類的市場是怎麼樣的？
根據給藥途徑，市場的分化為何？
基於配銷通路的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球神經退化性疾病治療市場的結構如何？
產業競爭程度如何？

Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.

The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type, route of administration and distribution channel.

Breakup by Indication:

Multiple Sclerosis

Parkinson's Disease

Alzheimer's Disease

Spinal Muscular Atrophy (SMA)

Huntington's Disease

Others

Breakup by Drug Type:

N-methyl-D-aspartate Receptor Antagonists

Selective Serotonin Reuptake Inhibitors

Dopamine Inhibitors

Others

Breakup by Route of Administration:

Oral

Injectable

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report:

How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
What are the key regional markets?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurodegenerative disease treatment market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurodegenerative Disease Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication

6.1 Multiple Sclerosis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Parkinson's Disease
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Alzheimer's Disease
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Spinal Muscular Atrophy (SMA)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Huntington's Disease
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast

7 Market Breakup by Drug Type

7.1 N-methyl-D-aspartate Receptor Antagonists
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Selective Serotonin Reuptake Inhibitors
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Dopamine Inhibitors
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Biogen
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Boehringer Ingelheim International GmbH
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 F. Hoffmann-La Roche AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 GlaxoSmithKline Plc
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 SWOT Analysis
- 15.3.5 Merck & Co. Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Novartis AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Pfizer Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Sanofi S.A
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Teva Pharmaceutical Industries Ltd.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 UCB S.A
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2023
Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2023
Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players

02-2729-4219

+886-2-2729-4219